๐ฐ Colitis Center News
Page 2 - Colitis Center News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Colitis Center. Real-time updates on events, politics, business and more.
May 9, 2023
/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new efficacy and safety data from the Phase 3 QUASAR Induction Study...
May 9, 2023
That cause chronic inflammation of the gastrointestinal tract.6 Prolonged inflammation results in damage to the GI tract.6 The exact cause of IBD is unknown but may be the result of the immune... | May 9, 2023
April 29, 2023
Clinicians now have two approved options for recurrent infections after antibiotic treatment.
April 18, 2023
Jessica Allegretti, MD, MPH, medical director of the Crohn's and Colitis Center, Brigham and Women's Hospital, reviews emerging therapeutics being investigated for the prevention and treatment of Clostridioides difficile infection (CDI).
April 2, 2023
Jessica Allegretti, MD, MPH, medical director of the Crohn's and Colitis Center, Brigham and Women's Hospital, speaks on current indications for Rebyota (fecal microbiota, live-jslm) in the treatment of recurrent Clostridioides difficile infection (CDI), as well as coverage and access-related implications for the drug.
March 30, 2023
Fecal transplants may have potential as an ulcerative colitis treatment, but people who want to try them have to go the DIY route. Learn about the risks.
March 22, 2023
Jessica Allegretti, MD, MPH, medical director of the Crohn's and Colitis Center, Brigham and Women's Hospital, discusses the standard of care for the prevention and treatment of primary and recurrent Clostridioides difficile infection (CDI).
January 31, 2023
The Bruce and Cynthia Sherman Charitable Foundation has announced the winners of the 2020 Sherman Prizes and the Emerging Leader Prize.
January 26, 2023
After studying the genetic sequences of more than 100,000 people, researchers around the country have started to uncover the root causes of inflammatory bowel disease (IBD), Crohn's disease, and ulcerative colitis.
October 19, 2022
Malvern, Pa. (PRWEB) October 19, 2022 -- HMP Global, the worldโs largest omnichannel healthcare events and education company, today announced that its